世界のウリジン市場予測 2023年-2029年

◆英語タイトル:Global Uridine Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23JU2465)◆商品コード:LP23JU2465
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年5月
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のウリジン市場」は、過去の販売実績から2022年の世界のウリジンの総販売量を検討し、2023年から2029年の予測されるウリジンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のウリジンの市場規模を掲載し、XXX百万米ドル規模の世界のウリジン市場の詳細な分析を提供します。本インサイトレポートは、世界のウリジン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のウリジン市場における各社の独自のポジションをより深く理解するために、ウリジン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のウリジン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ウリジンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。ウリジンの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ウリジンのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ウリジンの世界主要メーカーとしては、BioSpectra、 Venkatasai Life Sciences、 Tuoxin Pharmaceutical、 Meiya Pharmaceutical、 Fengchen Group、 Aosen New Material Technology Co、 Biocompounds Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のウリジン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではウリジン市場をセグメンテーションし、種類別 (純度99%以上、純度98%以上、その他)、用途別 (フルオロウラシル デオキシヌクレオシド、ヨードシド、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:純度99%以上、純度98%以上、その他

・用途別区分:フルオロウラシル デオキシヌクレオシド、ヨードシド、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のウリジン市場の10年間の市場状況・展望は?
・世界および地域別に見たウリジン市場成長の要因は何か?
・ウリジンの市場機会はエンドマーケットの規模によってどのように変化するのか?
・ウリジンのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ウリジンの年間販売量2018-2029、地域別現状・将来分析
・ウリジンの種類別セグメント:純度99%以上、純度98%以上、その他
・ウリジンの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・ウリジンの用途別セグメント:フルオロウラシル デオキシヌクレオシド、ヨードシド、その他
・ウリジンの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のウリジン市場
・企業別のグローバルウリジン市場データ:2018-2023年の年間販売量、市場シェア
・企業別のウリジンの年間売上:2018-2023年の売上、市場シェア
・企業別のウリジン販売価格
・主要企業のウリジン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ウリジンの地域別レビュー
・地域別のウリジン市場規模2018-2023:年間販売量、売上
・主要国別のウリジン市場規模2018-2023:年間販売量、売上
・南北アメリカのウリジン販売の成長
・アジア太平洋のウリジン販売の成長
・ヨーロッパのウリジン販売の成長
・中東・アフリカのウリジン販売の成長

南北アメリカ市場
・南北アメリカの国別のウリジン販売量、売上(2018-2023)
・南北アメリカのウリジンの種類別販売量
・南北アメリカのウリジンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のウリジン販売量、売上(2018-2023)
・アジア太平洋のウリジンの種類別販売量
・アジア太平洋のウリジンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のウリジン販売量、売上(2018-2023)
・ヨーロッパのウリジンの種類別販売量
・ヨーロッパのウリジンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のウリジン販売量、売上(2018-2023)
・中東・アフリカのウリジンの種類別販売量
・中東・アフリカのウリジンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ウリジンの製造コスト構造分析
・ウリジンの製造プロセス分析
・ウリジンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ウリジンの主要なグローバル販売業者
・ウリジンの主要なグローバル顧客

地域別のウリジン市場予測レビュー
・地域別のウリジン市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ウリジンの種類別市場規模予測
・ウリジンの用途別市場規模予測

主要企業分析
BioSpectra、 Venkatasai Life Sciences、 Tuoxin Pharmaceutical、 Meiya Pharmaceutical、 Fengchen Group、 Aosen New Material Technology Co、 Biocompounds Pharmaceutical
・企業情報
・ウリジン製品
・ウリジン販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

Uridine API in this report.
LPI (LP Information)’ newest research report, the “Uridine Industry Forecast” looks at past sales and reviews total world Uridine sales in 2022, providing a comprehensive analysis by region and market sector of projected Uridine sales for 2023 through 2029. With Uridine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Uridine industry.
This Insight Report provides a comprehensive analysis of the global Uridine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Uridine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Uridine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Uridine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Uridine.
The global Uridine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Uridine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Uridine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Uridine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Uridine players cover BioSpectra, Venkatasai Life Sciences, Tuoxin Pharmaceutical, Meiya Pharmaceutical, Fengchen Group, Aosen New Material Technology Co and Biocompounds Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Uridine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity More Than 99%
Purity More Than 98%
Others
Segmentation by application
Fluorouracil Deoxynucleoside
Iodoside
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BioSpectra
Venkatasai Life Sciences
Tuoxin Pharmaceutical
Meiya Pharmaceutical
Fengchen Group
Aosen New Material Technology Co
Biocompounds Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Uridine market?
What factors are driving Uridine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Uridine market opportunities vary by end market size?
How does Uridine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Uridine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Uridine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Uridine by Country/Region, 2018, 2022 & 2029
2.2 Uridine Segment by Type
2.2.1 Purity More Than 99%
2.2.2 Purity More Than 98%
2.2.3 Others
2.3 Uridine Sales by Type
2.3.1 Global Uridine Sales Market Share by Type (2018-2023)
2.3.2 Global Uridine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Uridine Sale Price by Type (2018-2023)
2.4 Uridine Segment by Application
2.4.1 Fluorouracil Deoxynucleoside
2.4.2 Iodoside
2.4.3 Others
2.5 Uridine Sales by Application
2.5.1 Global Uridine Sale Market Share by Application (2018-2023)
2.5.2 Global Uridine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Uridine Sale Price by Application (2018-2023)
3 Global Uridine by Company
3.1 Global Uridine Breakdown Data by Company
3.1.1 Global Uridine Annual Sales by Company (2018-2023)
3.1.2 Global Uridine Sales Market Share by Company (2018-2023)
3.2 Global Uridine Annual Revenue by Company (2018-2023)
3.2.1 Global Uridine Revenue by Company (2018-2023)
3.2.2 Global Uridine Revenue Market Share by Company (2018-2023)
3.3 Global Uridine Sale Price by Company
3.4 Key Manufacturers Uridine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Uridine Product Location Distribution
3.4.2 Players Uridine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Uridine by Geographic Region
4.1 World Historic Uridine Market Size by Geographic Region (2018-2023)
4.1.1 Global Uridine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Uridine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Uridine Market Size by Country/Region (2018-2023)
4.2.1 Global Uridine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Uridine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Uridine Sales Growth
4.4 APAC Uridine Sales Growth
4.5 Europe Uridine Sales Growth
4.6 Middle East & Africa Uridine Sales Growth
5 Americas
5.1 Americas Uridine Sales by Country
5.1.1 Americas Uridine Sales by Country (2018-2023)
5.1.2 Americas Uridine Revenue by Country (2018-2023)
5.2 Americas Uridine Sales by Type
5.3 Americas Uridine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Uridine Sales by Region
6.1.1 APAC Uridine Sales by Region (2018-2023)
6.1.2 APAC Uridine Revenue by Region (2018-2023)
6.2 APAC Uridine Sales by Type
6.3 APAC Uridine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Uridine by Country
7.1.1 Europe Uridine Sales by Country (2018-2023)
7.1.2 Europe Uridine Revenue by Country (2018-2023)
7.2 Europe Uridine Sales by Type
7.3 Europe Uridine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Uridine by Country
8.1.1 Middle East & Africa Uridine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Uridine Revenue by Country (2018-2023)
8.2 Middle East & Africa Uridine Sales by Type
8.3 Middle East & Africa Uridine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Uridine
10.3 Manufacturing Process Analysis of Uridine
10.4 Industry Chain Structure of Uridine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Uridine Distributors
11.3 Uridine Customer
12 World Forecast Review for Uridine by Geographic Region
12.1 Global Uridine Market Size Forecast by Region
12.1.1 Global Uridine Forecast by Region (2024-2029)
12.1.2 Global Uridine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Uridine Forecast by Type
12.7 Global Uridine Forecast by Application
13 Key Players Analysis
13.1 BioSpectra
13.1.1 BioSpectra Company Information
13.1.2 BioSpectra Uridine Product Portfolios and Specifications
13.1.3 BioSpectra Uridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioSpectra Main Business Overview
13.1.5 BioSpectra Latest Developments
13.2 Venkatasai Life Sciences
13.2.1 Venkatasai Life Sciences Company Information
13.2.2 Venkatasai Life Sciences Uridine Product Portfolios and Specifications
13.2.3 Venkatasai Life Sciences Uridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Venkatasai Life Sciences Main Business Overview
13.2.5 Venkatasai Life Sciences Latest Developments
13.3 Tuoxin Pharmaceutical
13.3.1 Tuoxin Pharmaceutical Company Information
13.3.2 Tuoxin Pharmaceutical Uridine Product Portfolios and Specifications
13.3.3 Tuoxin Pharmaceutical Uridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Tuoxin Pharmaceutical Main Business Overview
13.3.5 Tuoxin Pharmaceutical Latest Developments
13.4 Meiya Pharmaceutical
13.4.1 Meiya Pharmaceutical Company Information
13.4.2 Meiya Pharmaceutical Uridine Product Portfolios and Specifications
13.4.3 Meiya Pharmaceutical Uridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Meiya Pharmaceutical Main Business Overview
13.4.5 Meiya Pharmaceutical Latest Developments
13.5 Fengchen Group
13.5.1 Fengchen Group Company Information
13.5.2 Fengchen Group Uridine Product Portfolios and Specifications
13.5.3 Fengchen Group Uridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Fengchen Group Main Business Overview
13.5.5 Fengchen Group Latest Developments
13.6 Aosen New Material Technology Co
13.6.1 Aosen New Material Technology Co Company Information
13.6.2 Aosen New Material Technology Co Uridine Product Portfolios and Specifications
13.6.3 Aosen New Material Technology Co Uridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aosen New Material Technology Co Main Business Overview
13.6.5 Aosen New Material Technology Co Latest Developments
13.7 Biocompounds Pharmaceutical
13.7.1 Biocompounds Pharmaceutical Company Information
13.7.2 Biocompounds Pharmaceutical Uridine Product Portfolios and Specifications
13.7.3 Biocompounds Pharmaceutical Uridine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biocompounds Pharmaceutical Main Business Overview
13.7.5 Biocompounds Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Uridine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Uridine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity More Than 99%
Table 4. Major Players of Purity More Than 98%
Table 5. Major Players of Others
Table 6. Global Uridine Sales by Type (2018-2023) & (K MT)
Table 7. Global Uridine Sales Market Share by Type (2018-2023)
Table 8. Global Uridine Revenue by Type (2018-2023) & ($ million)
Table 9. Global Uridine Revenue Market Share by Type (2018-2023)
Table 10. Global Uridine Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Uridine Sales by Application (2018-2023) & (K MT)
Table 12. Global Uridine Sales Market Share by Application (2018-2023)
Table 13. Global Uridine Revenue by Application (2018-2023)
Table 14. Global Uridine Revenue Market Share by Application (2018-2023)
Table 15. Global Uridine Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Uridine Sales by Company (2018-2023) & (K MT)
Table 17. Global Uridine Sales Market Share by Company (2018-2023)
Table 18. Global Uridine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Uridine Revenue Market Share by Company (2018-2023)
Table 20. Global Uridine Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Uridine Producing Area Distribution and Sales Area
Table 22. Players Uridine Products Offered
Table 23. Uridine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Uridine Sales by Geographic Region (2018-2023) & (K MT)
Table 27. Global Uridine Sales Market Share Geographic Region (2018-2023)
Table 28. Global Uridine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Uridine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Uridine Sales by Country/Region (2018-2023) & (K MT)
Table 31. Global Uridine Sales Market Share by Country/Region (2018-2023)
Table 32. Global Uridine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Uridine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Uridine Sales by Country (2018-2023) & (K MT)
Table 35. Americas Uridine Sales Market Share by Country (2018-2023)
Table 36. Americas Uridine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Uridine Revenue Market Share by Country (2018-2023)
Table 38. Americas Uridine Sales by Type (2018-2023) & (K MT)
Table 39. Americas Uridine Sales by Application (2018-2023) & (K MT)
Table 40. APAC Uridine Sales by Region (2018-2023) & (K MT)
Table 41. APAC Uridine Sales Market Share by Region (2018-2023)
Table 42. APAC Uridine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Uridine Revenue Market Share by Region (2018-2023)
Table 44. APAC Uridine Sales by Type (2018-2023) & (K MT)
Table 45. APAC Uridine Sales by Application (2018-2023) & (K MT)
Table 46. Europe Uridine Sales by Country (2018-2023) & (K MT)
Table 47. Europe Uridine Sales Market Share by Country (2018-2023)
Table 48. Europe Uridine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Uridine Revenue Market Share by Country (2018-2023)
Table 50. Europe Uridine Sales by Type (2018-2023) & (K MT)
Table 51. Europe Uridine Sales by Application (2018-2023) & (K MT)
Table 52. Middle East & Africa Uridine Sales by Country (2018-2023) & (K MT)
Table 53. Middle East & Africa Uridine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Uridine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Uridine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Uridine Sales by Type (2018-2023) & (K MT)
Table 57. Middle East & Africa Uridine Sales by Application (2018-2023) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Uridine
Table 59. Key Market Challenges & Risks of Uridine
Table 60. Key Industry Trends of Uridine
Table 61. Uridine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Uridine Distributors List
Table 64. Uridine Customer List
Table 65. Global Uridine Sales Forecast by Region (2024-2029) & (K MT)
Table 66. Global Uridine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Uridine Sales Forecast by Country (2024-2029) & (K MT)
Table 68. Americas Uridine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Uridine Sales Forecast by Region (2024-2029) & (K MT)
Table 70. APAC Uridine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Uridine Sales Forecast by Country (2024-2029) & (K MT)
Table 72. Europe Uridine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Uridine Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Middle East & Africa Uridine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Uridine Sales Forecast by Type (2024-2029) & (K MT)
Table 76. Global Uridine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Uridine Sales Forecast by Application (2024-2029) & (K MT)
Table 78. Global Uridine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. BioSpectra Basic Information, Uridine Manufacturing Base, Sales Area and Its Competitors
Table 80. BioSpectra Uridine Product Portfolios and Specifications
Table 81. BioSpectra Uridine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. BioSpectra Main Business
Table 83. BioSpectra Latest Developments
Table 84. Venkatasai Life Sciences Basic Information, Uridine Manufacturing Base, Sales Area and Its Competitors
Table 85. Venkatasai Life Sciences Uridine Product Portfolios and Specifications
Table 86. Venkatasai Life Sciences Uridine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Venkatasai Life Sciences Main Business
Table 88. Venkatasai Life Sciences Latest Developments
Table 89. Tuoxin Pharmaceutical Basic Information, Uridine Manufacturing Base, Sales Area and Its Competitors
Table 90. Tuoxin Pharmaceutical Uridine Product Portfolios and Specifications
Table 91. Tuoxin Pharmaceutical Uridine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Tuoxin Pharmaceutical Main Business
Table 93. Tuoxin Pharmaceutical Latest Developments
Table 94. Meiya Pharmaceutical Basic Information, Uridine Manufacturing Base, Sales Area and Its Competitors
Table 95. Meiya Pharmaceutical Uridine Product Portfolios and Specifications
Table 96. Meiya Pharmaceutical Uridine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Meiya Pharmaceutical Main Business
Table 98. Meiya Pharmaceutical Latest Developments
Table 99. Fengchen Group Basic Information, Uridine Manufacturing Base, Sales Area and Its Competitors
Table 100. Fengchen Group Uridine Product Portfolios and Specifications
Table 101. Fengchen Group Uridine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Fengchen Group Main Business
Table 103. Fengchen Group Latest Developments
Table 104. Aosen New Material Technology Co Basic Information, Uridine Manufacturing Base, Sales Area and Its Competitors
Table 105. Aosen New Material Technology Co Uridine Product Portfolios and Specifications
Table 106. Aosen New Material Technology Co Uridine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Aosen New Material Technology Co Main Business
Table 108. Aosen New Material Technology Co Latest Developments
Table 109. Biocompounds Pharmaceutical Basic Information, Uridine Manufacturing Base, Sales Area and Its Competitors
Table 110. Biocompounds Pharmaceutical Uridine Product Portfolios and Specifications
Table 111. Biocompounds Pharmaceutical Uridine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Biocompounds Pharmaceutical Main Business
Table 113. Biocompounds Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Uridine
Figure 2. Uridine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Uridine Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Uridine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Uridine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity More Than 99%
Figure 10. Product Picture of Purity More Than 98%
Figure 11. Product Picture of Others
Figure 12. Global Uridine Sales Market Share by Type in 2022
Figure 13. Global Uridine Revenue Market Share by Type (2018-2023)
Figure 14. Uridine Consumed in Fluorouracil Deoxynucleoside
Figure 15. Global Uridine Market: Fluorouracil Deoxynucleoside (2018-2023) & (K MT)
Figure 16. Uridine Consumed in Iodoside
Figure 17. Global Uridine Market: Iodoside (2018-2023) & (K MT)
Figure 18. Uridine Consumed in Others
Figure 19. Global Uridine Market: Others (2018-2023) & (K MT)
Figure 20. Global Uridine Sales Market Share by Application (2022)
Figure 21. Global Uridine Revenue Market Share by Application in 2022
Figure 22. Uridine Sales Market by Company in 2022 (K MT)
Figure 23. Global Uridine Sales Market Share by Company in 2022
Figure 24. Uridine Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Uridine Revenue Market Share by Company in 2022
Figure 26. Global Uridine Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Uridine Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Uridine Sales 2018-2023 (K MT)
Figure 29. Americas Uridine Revenue 2018-2023 ($ Millions)
Figure 30. APAC Uridine Sales 2018-2023 (K MT)
Figure 31. APAC Uridine Revenue 2018-2023 ($ Millions)
Figure 32. Europe Uridine Sales 2018-2023 (K MT)
Figure 33. Europe Uridine Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Uridine Sales 2018-2023 (K MT)
Figure 35. Middle East & Africa Uridine Revenue 2018-2023 ($ Millions)
Figure 36. Americas Uridine Sales Market Share by Country in 2022
Figure 37. Americas Uridine Revenue Market Share by Country in 2022
Figure 38. Americas Uridine Sales Market Share by Type (2018-2023)
Figure 39. Americas Uridine Sales Market Share by Application (2018-2023)
Figure 40. United States Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Uridine Sales Market Share by Region in 2022
Figure 45. APAC Uridine Revenue Market Share by Regions in 2022
Figure 46. APAC Uridine Sales Market Share by Type (2018-2023)
Figure 47. APAC Uridine Sales Market Share by Application (2018-2023)
Figure 48. China Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Uridine Sales Market Share by Country in 2022
Figure 56. Europe Uridine Revenue Market Share by Country in 2022
Figure 57. Europe Uridine Sales Market Share by Type (2018-2023)
Figure 58. Europe Uridine Sales Market Share by Application (2018-2023)
Figure 59. Germany Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Uridine Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Uridine Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Uridine Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Uridine Sales Market Share by Application (2018-2023)
Figure 68. Egypt Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Uridine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Uridine in 2022
Figure 74. Manufacturing Process Analysis of Uridine
Figure 75. Industry Chain Structure of Uridine
Figure 76. Channels of Distribution
Figure 77. Global Uridine Sales Market Forecast by Region (2024-2029)
Figure 78. Global Uridine Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Uridine Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Uridine Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Uridine Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Uridine Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のウリジン市場予測 2023年-2029年(Global Uridine Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆